Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where a protected amino acid moiety is required. Its structure allows for selective functionalization in multi-step organic syntheses, especially in the preparation of peptidomimetics and drug candidates targeting central nervous system disorders. The Boc-protected amine group enables controlled deprotection under mild acidic conditions, making it valuable in solid-phase and solution-phase peptide synthesis. Additionally, the chlorophenyl group can serve as a handle for further cross-coupling reactions or as a structural element to influence bioavailability and binding affinity in medicinal chemistry.